AU5073400A - Sulfonamide compounds with pharmaceutical activity - Google Patents

Sulfonamide compounds with pharmaceutical activity

Info

Publication number
AU5073400A
AU5073400A AU50734/00A AU5073400A AU5073400A AU 5073400 A AU5073400 A AU 5073400A AU 50734/00 A AU50734/00 A AU 50734/00A AU 5073400 A AU5073400 A AU 5073400A AU 5073400 A AU5073400 A AU 5073400A
Authority
AU
Australia
Prior art keywords
pharmaceutical activity
sulfonamide compounds
sulfonamide
compounds
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU50734/00A
Inventor
Peter John Lovell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Publication of AU5073400A publication Critical patent/AU5073400A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/46Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
    • C07D207/48Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
AU50734/00A 1999-06-01 2000-05-25 Sulfonamide compounds with pharmaceutical activity Abandoned AU5073400A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9912701 1999-06-01
GBGB9912701.1A GB9912701D0 (en) 1999-06-01 1999-06-01 Novel compounds
PCT/EP2000/004893 WO2000073299A1 (en) 1999-06-01 2000-05-25 Sulfonamide compounds with pharmaceutical activity

Publications (1)

Publication Number Publication Date
AU5073400A true AU5073400A (en) 2000-12-18

Family

ID=10854529

Family Applications (1)

Application Number Title Priority Date Filing Date
AU50734/00A Abandoned AU5073400A (en) 1999-06-01 2000-05-25 Sulfonamide compounds with pharmaceutical activity

Country Status (5)

Country Link
EP (1) EP1181287A1 (en)
JP (1) JP2003500488A (en)
AU (1) AU5073400A (en)
GB (1) GB9912701D0 (en)
WO (1) WO2000073299A1 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040267010A1 (en) * 2001-02-02 2004-12-30 Forbes Ian Thomson Sulfonamide compounds, their preparation and use
WO2004014428A1 (en) * 2002-08-09 2004-02-19 Ajinomoto Co.,Inc. Remedy for intestinal diseases and visceral pain
WO2004069828A1 (en) * 2003-02-04 2004-08-19 Mitsubishi Pharma Corporation Piperidine compound and medicinal use thereof
GB0311201D0 (en) 2003-05-15 2003-06-18 Merck Sharp & Dohme Therapeutic agents
AU2004283196B2 (en) 2003-09-17 2011-08-25 Janssen Pharmaceutica, N.V. Fused heterocyclic compounds
MX2008000017A (en) 2005-06-28 2008-03-26 Sanofi Aventis Isoquinoline derivatives as inhibitors of rho-kinase.
PT1910333E (en) 2005-07-26 2013-08-01 Sanofi Sa Piperidinyl-substituted isoquinolone derivatives as rho-kinase inhibitors
US7598255B2 (en) 2005-08-04 2009-10-06 Janssen Pharmaceutica Nv Pyrimidine compounds as serotonin receptor modulators
PT2102164E (en) 2006-12-27 2011-01-21 Sanofi Aventis Cycloalkylamine substituted isoquinoline and isoquinolinone derivatives
AU2007338408B2 (en) 2006-12-27 2012-07-26 Sanofi-Aventis Substituted isoquinoline and isoquinolinone derivatives
BRPI0720909A2 (en) 2006-12-27 2016-11-01 Sanofi Aventis substituted isoquinoline and isoquinolinone derivatives
JP5405316B2 (en) 2006-12-27 2014-02-05 サノフイ Cycloalkylamine substituted isoquinoline derivatives
MY155009A (en) 2006-12-27 2015-08-28 Sanofi Aventis Cycloalkylamine substituted isoquinolone derivatives
BRPI0720862A2 (en) 2006-12-27 2014-02-25 Sanofi Aventis ISOKINOLINE AND ISOQUINOLINONE DERIVATIVES REPLACED AS RHO-KINASE INHIBITORS
EP2303845B1 (en) 2008-06-24 2013-09-18 Sanofi Bi-and polycyclic substituted isoquinoline and isoquinoline derivatives as rho kinase inhibitors
JP5713893B2 (en) 2008-06-24 2015-05-07 サノフイ Substituted isoquinolines and isoquinolinones as Rho-kinase inhibitors
CN102131785B (en) 2008-06-24 2014-10-29 赛诺菲-安万特 6-substituted isoquinolines and isoquinolinones
JP5641436B2 (en) * 2011-03-28 2014-12-17 国立大学法人 鹿児島大学 Anti-HIV drugs
CN112437768A (en) * 2018-05-11 2021-03-02 英联邦高等教育***坦普尔大学 Novel functionalized lactams as 5-hydroxytryptamine receptor 7 modulators and methods of use thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997029097A1 (en) * 1996-02-09 1997-08-14 Smithkline Beecham Plc Sulfonamide derivatives as 5ht7 receptor antagonists
GB9612884D0 (en) * 1996-06-20 1996-08-21 Smithkline Beecham Plc Novel compounds
US6025367A (en) * 1996-06-25 2000-02-15 Smithkline Beecham Plc Sulfonamide derivatives as 5HT7 receptor antagonists
JP2001526178A (en) * 1997-08-28 2001-12-18 メルク エンド カムパニー インコーポレーテッド Pyrrolidine and piperidine chemokine receptor activity modulators

Also Published As

Publication number Publication date
EP1181287A1 (en) 2002-02-27
WO2000073299A1 (en) 2000-12-07
JP2003500488A (en) 2003-01-07
GB9912701D0 (en) 1999-08-04

Similar Documents

Publication Publication Date Title
AU3569800A (en) Pyrimidine compounds with pharmaceutical activity
AU1071301A (en) Pharmaceutical compounds
AU5259100A (en) Medicament
AU2278601A (en) Dual-mode processor
HU0004123D0 (en) New compounds with pharmaceutical activity
AU1225000A (en) Combined pharmaceutical estrogen-androgen-progestin
AU2164101A (en) Fungicidal combinations of active substances
AU5073400A (en) Sulfonamide compounds with pharmaceutical activity
AU2919001A (en) Syringe
AU2270101A (en) Pharmaceutical kit
AU4328800A (en) Pharmaceutical formulation
AU5691800A (en) Structure
AU3838400A (en) Processor
AU1645700A (en) Oenothein medicaments
AU6748500A (en) 9a-azalides with antibacterial activity
AU2543600A (en) Fungicidal active substance combinations
AU4977300A (en) Pharmaceutical formulations
AU5722900A (en) Pharmaceutical compounds
AU6036100A (en) New pharmaceutically active compounds
AU2201501A (en) Structure
AU1385801A (en) Pharmaceutical formulations
AU6480299A (en) Pharmaceutical compounds
AU7450300A (en) Sulfonamide derivatives
AU3839900A (en) Pharmaceutical formulation
AU3988100A (en) Processor

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase